Get started
Author

Ágnes Kerényi

Observed names: Agnes Kerenyi, Kerényi Ágnes
ORCID: 0009-0007-0275-0402
Observed ORCID: 0009-0007-0275-0402
OpenAlex ID: A5062518529
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
2023 · Arshad M Khanani, Sunil S Patel, et al. · The Lancet · 401
PDF
TENAYA and LUCERNE
2024 · Arshad M. Khanani, Aachal Kotecha, et al. · Ophthalmology · 266
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 198
PDF
Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
2014 · Yuichiro Ogura, Johann Roider, et al. · American Journal of Ophthalmology · 165
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 160
PDF
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept
2019 · Justus G. Garweg, Jana Stefanickova, et al. · Ophthalmology Retina · 35
PDF
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial
2024 · Susan B. Bressler, Abhijit Barve, et al. · JAMA Ophthalmology · 23
PDF
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
2023 · Masahiko Shimura, Shigehiko Kitano, et al. · Japanese Journal of Ophthalmology · 23
PDF
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
2022 · Justus G. Garweg, Jana Štefanickova, et al. · Advances in Therapy · 19
PDF
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial
2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 15
Corneal topographic results after eccentric, biconvex penetrating keratoplasty
2003 · Ágnes Kerényi, Ildikó Süveges · Journal of Cataract & Refractive Surgery · 15
Randomized Trial of Biosimilar ABP 938 Compared with Reference Aflibercept in Adults with Neovascular Age-Related Macular Degeneration
2025 · Scott Friedman, Nikolas London, et al. · Ophthalmology Retina · 11
C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty
2002 · Ágnes Kerényi, György Nagy, et al. · Current Eye Research · 10
Leiomyoma of the ciliary body and hemangiopericytoma of the choroid
1996 · Jeannette Tóth, Ágnes Kerényi, et al. · Pathology & Oncology Research · 10
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration
2024 · Jan Hamouz, Agnieszka Nowosielska, et al. · Ophthalmology Retina · 5
Potential 20-Week Faricimab Dosing in Wet Age-Related Macular Degeneration
2026 · Aude Ambresin, Varun Chaudhary, et al. · Ophthalmology Retina · 3
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics
2026 · Richard P. Gale, Anat Loewenstein, et al. · Ophthalmology Retina · 2
Posterior Chamber Intraocular Lens Dislocation Into the Vitreous in Association With Descemet Stripping Lamellar Keratoplasty
2022 · Kristóf Dániel Rodler, Tamás Pregun, et al. · Cornea · 2
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
2025 · Kiyoshi Suzuma, Toshinori Murata, et al. · Japanese Journal of Ophthalmology · 1
PDF
Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension
2026 · Justus G. Garweg, Varun Chaudhary, et al. · Ophthalmology Retina
Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial
2026 · Jean-François Korobelnik, Sergio Leal, et al. · Eye
Reply
2025 · Scott Friedman, Nikolas London, et al. · Ophthalmology Retina
Mycoplasma pneumoniae fertőzéssel összefüggésbe hozható intraocularis gyulladás (esetismertetés és irodalmi áttekintés)
2024 · Réka Kálmán, Tamás Pregun, et al. · Szemészet
PDF
A SARS CoV-2-fertőzés miatt kórházunk COVID-osztályán kezelt betegek makulatáji vizsgálata
2022 · Réka Kálmán, Petra Gáspár, et al. · Szemészet
Works count: 24
Citation count: 1,364
H-index: 11
I10-index: 14
Year
Topic
Type